Skip to main content

Aeglea BioTherapeutics Value Stock - Dividend - Research Selection

Aeglea biotherapeutics

ISIN: US00773J1034 , WKN: A2AG5H

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients with rare genetic and cancer diseases. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme which is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. Its preclinical pipeline products comprise ACN00177, a product candidate for the treatment of homocystinuria; AEB5100, a recombinant human enzyme that degrades plasma cystine and cysteine; AEB2109, an engineered human enzyme that targets the degradation of the amino acid methionine; and AEB3103, a product candidate. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Tellus Equipment Solutions Acquires Dealership Locations in Marble Falls, San Antonio, and Bulverde

KATY, Texas--(BUSINESS WIRE)--November 28, 2023-- Tellus Equipment Solutions ("Tellus"), a premier John Deere Agricultural and Turf dealer, is pleased to...

oceansix future paths Ltd. Publishes QIII/2023 Results

Highlights QIII/2023: -- Product launch: HydroQuick, the ultra-efficient hydroponic cultivation system -- R&D development: positive progress with the patent...

New Brunswick man fined $50,000 for use of a professional engineer's seal

TORONTO, Nov. 28, 2023 /CNW/ - The Ontario Court of Justice at Kitchener fined a New Brunswick man, JAY LAWRENCE HARDING, $50,000 for using a fabricated...

HES Employee Wellness Program Participants Log 14 Million Miles in Walktober

Fall walking challenge sets all-time record for participation, engagement, and results.MIDLAND, Mich.--(BUSINESS WIRE)--November 28, 2023-- Health...

MoU - South Sudan

CALGARY, AB / ACCESSWIRE / November 28, 2023 / Zenith Energy Ltd. (LSE:ZEN)(OSE:ZENA)(OTCQB:ZENAF), the listed international energy production and...

Rosalind Franklin University Innovation and Research Park Welcomes Three Squared Biosciences, Focused on Gut Microbiome Solutions for Chronic Diseases

Rosalind Franklin University Innovation and Research Park Welcomes Three Squared Biosciences, Focused on Gut Microbiome Solutions for Chronic Diseases PR...

Petalfast Joins Forces With Revelry Herb Co. in California

IRVINE, CA / ACCESSWIRE / November 28, 2023 / Petalfast, a leading national sales, marketing and distribution platform for the cannabis industry, announced...

CubiCasa and OneKey(R) MLS Forge Digital Floor Plan Partnership

CubiCasa's Easy-to-Use Floor Plan Creation Tool Coming to One of the Nation's Largest MLSs SAN JOSE, CA / ACCESSWIRE / November 28, 2023 / CubiCasa, a...

5 Tips for Safe Holiday Travel

5 Tips for Safe Holiday Travel PR Newswire MISSION, Kan., Nov. 28, 2023 MISSION, Kan., Nov. 28, 2023 /PRNewswire/ -- (Family Features) The holiday season can...

Fed's Waller says economy is slowing, unsure if more rates hikes needed to tame inflation

Federal Reserve Gov. Chris Waller said recent signs of a slowdown in the economy could help return inflation to the central bank's 2% target, but he said...